New lung cancer drug may ‘extend life’

Rate this post

Researchers say a new drug can reduce the chances of dying by a quarter and extend life for women with advanced lung cancer.

Drug trials carried out by Cancer Research UK, found that 15% of women had no progression of their cancer 12 months after taking the drug compared with only 5% of those on a placebo.
Dr Siow Ming Lee, trial leader and senior lecturer at the University College London Cancer Institute, stated “These results are a real step forward in the search for an effective treatment for patients with advanced lung cancer.”

The drug works by interfering with how cancer cells multiply and could offer hope to patients too sick for conventional chemotherapy.


Please enter your comment!
Please enter your name here